Big Pharma loves Obama Care

Image via Wikipedia

Brian Schwartz
From Tim Carney’s article in the Washington Examiner, Dems tap drug maker millions for PhRMA-friendly bill:

Of all the single-industry lobbies in Washington, the largest is the Pharmaceutical Researchers and Manufacturers of America. PhRMA spent $26.2 million on lobbying last year — that’s nearly three times as much as the insurance lobby, America’s Health Insurance Plans, which spent $8.9 million.

If you include individual companies’ lobbying, pharmaceuticals blow away the competition, beating all other industries by 50 percent, according to data at the Center for Responsive Politics.

Given this Big Pharma clout, it’s unsurprising that the bill Obama’s whipping for — Senate bill — has nearly everything the drug companies wanted: prohibiting reimportation of drugs, preserving Medicare’s overpayment for drugs, lengthy exclusivity for biotech drugs, a mandate that states subsidize drugs under Medicaid, hundreds of billions in subsidies for drugs, and more.

Read the whole article: Dems tap drug maker millions for PhRMA-friendly bill.

Research center using babies and children for experimental H1N1 Vaccine

The Warwick Beacon reports Omega Medical Research, a privately owned clinical research center providing clinical research services to the pharmaceutical industry, will "study three different vaccines on three different age groups. Roughly 300 adults will receive an injectable vaccine. The study will also include about 40-60 children between the ages of 2 and 17 and 40 infants and toddlers between six to 35 months old. Some of the patients in the younger age groups will get injections, while others will receive nasal sprays."

Patients will receive compensation for their participation in the study. Adult participants will receive up to $540, children up to $350 and the youngest group, up to $520.

According to their website, Omega Medical Research claims over 6,000 patients have been registered as study subjects for various trials. "Additionally, Dr. Fried [OMR's Medical Director and Principal Investigator] enjoys his own private practice of over 12,000 primary care patients, as well as being part of a regional primary care practice of 35 physicians who, collectively, have well over 200,000 patients. As such, recruitment is a streamlined process, utilizing an ever-expanding database of potential subjects."

So Dr. Fried and his clinic volunteer the services of his patients and the patients of 35 other doctors as guinea pigs to the drug companies for a fee.

“It’s a unique opportunity for the residents of Rhode Island to get vaccinated,” says Lynn Haughey, a nurse practitioner and co-owner of the Omega Medical Research center. Haughey claims that during the study participants will not actually be exposed to live novel H1N1 viruses, but thy will be exposed to their antigens.

Rhode Island Department of Health spokeswoman Annemarie Beardsworth said the clinical vaccine will likely be produced by one of five pharmaceutical companies: SanofiPasteur, GlaxoSmithKline, Novartis, CSL Biotherapies or MedImmune. So, if a manufacturer experiences a mishap while making a vaccine, there will be others working toward the same goal.